News

Revolutionizing Patient Care with Avextra's Breakthrough Capsules

Revolutionizing Patient Care with Avextra's Breakthrough Capsules

Avextra's Innovative Approach to Patient-Centric Therapy

With evidence-based clinical development and new pharmaceutical formulations, Avextra aims to enhance patient experience and adherence.

In the ever-evolving realm of medical therapies, the question arises: How can treatments involving Cannabis-based medicines (CbM) be both effective and user-friendly? Traditionally, oily solutions have dominated the market, particularly for pain management. However, despite their proven effectiveness, these solutions often lack convenience. Recognizing this challenge, Avextra, a pioneering German biotech firm, is making significant strides with the launch of a new line of products that includes capsules, a more standardized and potentially easier-to-use dosage form.

The Role of Avextra Capsules in Patient Care

Crafted with care, these capsules are filled with granulates containing Avextra's proprietary Cannabis extract, formulated as Avextra 10:10 (THC/CBD). Their introduction follows a comprehensive study designed to evaluate patient satisfaction across various oral cannabis forms. This extensive, prospective multicentric SATURN study included almost 400 participants across 24 centers, aiming to improve quality of life (QoL) in pain patients through personalized treatment approaches.

Impressive Outcomes from the SATURN Study

The SATURN study yielded remarkable findings after participants had undergone three months of treatment. Both the oily Cannabis extract Avextra 10:10 and the new Cannabis extract capsules showed superior results in alleviating symptoms while enhancing quality of life for users. Notably, treatment with the Avextra capsules (available in 2.5 mg and 5 mg THC/CBD ratios) displayed significantly better outcomes compared to the existing extracts. Patients reported a marked improvement in conditions like sleep disturbances, chronic pain from various ailments, and overall health perceptions.

Key Insights from Patient-Reported Experiences

The results of the SATURN study are compelling:

  • Efficacy: The Avextra capsules exhibited substantially higher responder rates for quality of life improvements and symptom relief compared to traditional cannabis extracts after six months of treatment.
  • Medication Reduction: A notable 37% of patients reported a decrease in their previous medications, including analgesics and antidepressants, as a direct result of using Avextra’s products.
  • High Patient Satisfaction: Satisfaction levels soared, with 68% of users expressing contentment with the oily extract and an impressive 90% satisfied with the new capsule form.
  • Therapy Continuation: Remarkably, 85% of patients indicated they would opt for Avextra’s cannabis medications again, showcasing the strong belief in the product's effectiveness.

Commitment to Advancing Cannabis Medicine

The findings from SATURN are a testament to the importance of developing patient-oriented, standardized oral medications that enhance usability and maintain therapeutic efficacy. Avextra’s introduction of the capsule line signifies an essential step toward offering accessible and effective cannabinoid-based treatment options.

Expert Commentary on the Research Findings

Reflecting on the SATURN study, Prof. Dr. med. Justus Benrath, the principal investigator, emphasized the importance of including a diverse array of patients, from those new to cannabis therapies to experienced users. This approach allowed for a comprehensive evaluation of how these treatments impact patient satisfaction, quality of life, and overall tolerability.

Ongoing Commitment to Research and Development

Avextra remains steadfast in its dedication to further research, aiming to explore the long-term benefits of cannabinoid therapies in areas where patient needs are significant and unmet. Dr. Bernhard Babel, CEO of Avextra, stated that patient-related outcomes and individual treatment goals are integral to the development of future studies, allowing for deeper insights into effective treatment solutions for severely ill patients. This reinforces the recognition that cannabis medicines are generally well tolerated and contribute positively to pain management.

About Avextra AG

Avextra is a German biotechnology company committed to pioneering cannabis-based prescription medicines. The firm is heavily invested in innovative research, currently conducting multiple groundbreaking studies aimed at regulatory approval to enhance the treatment landscape for patients requiring pain management and palliative care. The company's mission is to develop effective strategies that improve the reimbursement process for cannabinoid therapies.

For further inquiries, please reach out to Avextra’s dedicated media contact:

Avextra Media Enquiries:

Email: press@avextra.com | Phone: +49 30 408174037

Frequently Asked Questions

What type of products does Avextra offer?

Avextra specializes in cannabis-based prescription medications, focusing on standardized oral dosage forms like capsules.

How many patients were involved in the SATURN study?

Nearly 400 patients participated in the SATURN study, which evaluated various oral cannabis products.

What improvements did patients report after using Avextra capsules?

Patients experienced significant improvements in symptom relief and overall quality of life.

What percentage of patients wanted to continue using Avextra products?

85% of patients expressed their willingness to use Avextra cannabis medications again.

What is Avextra's main goal in conduct research?

Avextra aims to enhance the reimbursement process for cannabinoid treatments, ensuring better access for patients in pain management and palliative care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 72

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading
Leatt Sets Its Virtual 2026 Shareholder Meeting Date

Updated Category News Views 73

A calendar notice is not a catalyst, but ignoring the calendar is how shareholders miss the small moments that matter. Leatt Corporation has scheduled its 2026 virtual annual general meeting of stockholders for Friday, November 20, at 11:00 AM Eastern Time. For holders of OTCQB:LEAT, this is a basic corporate-governance event, not a new product launch or a financial...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Devicie Broadens Browser Security Across Device Fleets

Updated Category News Views 57

Browsers have quietly become the front door, side door, and occasionally the busted basement window of corporate security. Devicie’s newly expanded Edge for Business Reporting Connector tackles that uncomfortable reality by pulling browser security events from Windows, macOS, iOS, and Android into the same console customers use to oversee Microsoft Intune environments....

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 92

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MetaOptics Tests a Real Path Into Secure Imaging Markets

Updated Category News Views 77

Fingerprint scanners have never impressed me much; fooling one is exactly the sort of nuisance that keeps security buyers spending. MetaOptics’ new collaboration with Hong Kong’s ASTRI goes after that uncomfortable problem with a compact nano-optics imaging system built for biometric security and smart sensing. It is a sensible target. It is also, at this stage, a...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 109

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 48

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 96

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 87

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Jordyn Poulter Shines in Times Square After Olympic Success

Updated Category News Views 419

Jordyn Poulter Shines in Times Square After Olympic Success Attention volleyball fans and supporters of women's sports: professional women's volleyball has officially made its mark in the United States. Today, a stunning billboard featuring Olympic silver medalist Jordyn Poulter was unveiled in the bustling Times Square of New York City. Poulter previously played for UYBA...

Continue Reading
Lifecore Biomedical Plans Exciting Financial Update Soon

Updated Category News Views 260

Lifecore Biomedical Prepares to Share Financial Insights Lifecore Biomedical, Inc. (NASDAQ: LFCR) is gearing up to share its financial outcomes for the second quarter of fiscal year 2025 in early January. This exciting announcement marks a significant moment for the company, which is known for its expertise in the contract development and manufacturing landscape. What to...

Continue Reading
Peloton Interactive, Inc. Sets Earnings Call for Q1 of 2025

Updated Category News Views 86

Peloton Interactive, Inc. Earnings Call Announcement Peloton Interactive, Inc. (NASDAQ: PTON) is gearing up for an important announcement regarding its financial results. The company will share its first quarter fiscal 2025 results before the stock market opens on a Thursday in late October. This is a key moment for both the company and its investors, as it lays out the...

Continue Reading
Centerspace Boosts Core FFO Guidance Amid Market Challenges

Updated Category News Views 159

Centerspace's Successful Third Quarter Performance Centerspace (NYSE: CSR), a prominent real estate investment trust, reported a strong third quarter performance in 2024 during its recent earnings call. The company announced a core funds from operations (FFO) of $1.18 per share, reflecting a notable 3% rise in same-store revenue, alongside an improved occupancy rate of...

Continue Reading
Ammunition Depot Crowned as Leading Online Ammo Retailer

Updated Category News Views 277

Ammunition Depot Crowned as Leading Online Ammo Retailer Ammunition Depot has been recognized as the best online destination for purchasing ammunition, according to a recent feature in Guns & Ammo Magazine. This accolade highlights their dedication to delivering a remarkable customer experience complemented by fast shipping and extensive product offerings. In a detailed...

Continue Reading